Compound 1202
Identifiers
- Canonical SMILES:
CCC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(CC2=C(CC(C)(C)CC2)c2ccc(Cl)cc2)CC1
- InChi:
InChI=1S/C48H63ClN6O4S3/c1-7-11-37(32-60-39-12-9-8-10-13-39)52-43-19-18-40(28-45(43)61(56,57)47(2,3)4)62(58,59)53-46-41-23-27-55(31-44(41)50-33-51-46)38-21-25-54(26-22-38)30-35-20-24-48(5,6)29-42(35)34-14-16-36(49)17-15-34/h8-10,12-19,28,33,37-38,52H,7,11,20-27,29-32H2,1-6H3,(H,50,51,53)/t37-/m1/s1
- InChiKey:
SUCMWQBKNHGKJQ-DIPNUNPCSA-N
External links
![]() 168317873 |
External search
|
|
|
|
|
Bibliography (1)
| Publication | Name |
|---|---|
| Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 18 |
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| BCL2-Like / BAX | 6.24 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 918.38 g/mol | |||
| HBA | 10 | |||
| HBD | 2 | |||
| HBA + HBD | 12 | |||
| AlogP | 7.81 | |||
| TPSA | 124.60 | |||
| RB | 15 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|---|---|---|---|---|---|---|---|
| WO2011029842 | 18 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 6.24 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.5737 | Navitoclax | DB12340 | |
| 0.4130 | Venetoclax | DB11581 | |
| 0.3799 | (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE | DB08039 | |
| 0.3771 | Presatovir | DB12165 | |
| 0.3695 | Cyclothiazide | DB00606 | |
| 0.3634 | (4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol | DB08448 | |
| 0.3616 | Vintafolide | DB05168 | |
| 0.3583 | GDC-0349 | DB13072 | |
| 0.3571 | Sulfaisodimidine | DB13283 | |
| 0.3562 | 2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID | DB07323 | |
| 0.3562 | Tianeptine | DB09289 | |
| 0.3538 | Quinupristin | DB01369 | |
| 0.3535 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
| 0.3513 | Ceritinib | DB09063 | |
| 0.3508 | SU-11652 | DB08009 |




